6-amino-1-hydroxyhexane-1,1-diphosphonate and Osseous Paget's Disease

Research

Authors	Studies
Arianna, R; Colao, A; DI Benedetto, E; DI Somma, C; Riccio, E; Romano, F; Scarano, E	1
Fassio, A; Gatti, D; Idolazzi, L; Rossini, M; Viapiana, O	1
Adami, G; Braga, V; Fassio, A; Gatti, D; Idolazzi, L; Rossini, M; Tripi, G; Viapiana, O	1
De Paola, V; Gennari, L; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D	1
Adami, S; Fracassi, E; Gatti, D; Idolazzi, L; Viapiana, O	1
Avanzati, A; Campagna, MS; De Filippo, G; Franci, B; Gennari, L; Gianfrancesco, F; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D; Strazzullo, P	1
Avanzati, A; De Paola, V; Gennari, L; Martini, G; Merlotti, D; Nuti, R; Valleggi, F	1
Casciari, C; Cristallini, S; Filipponi, P; Gregorio, F; Policani, G	1
Chapuy, MC; Delmas, PD; Edouard, C; Meunier, PJ	1

2 review(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Osseous Paget's Disease

Article	Year
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone. Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:9 Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Osteitis Deformans; Pamidronate; Zoledronic Acid	2009
Neridronic acid for the treatment of bone metabolic diseases. Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:10 Topics: Adult; Bone Diseases, Metabolic; Child; Child, Preschool; Clinical Trials as Topic; Diphosphonates; Drug Evaluation, Preclinical; Humans; Infant; Infant, Newborn; Italy; Osteitis Deformans; Osteogenesis Imperfecta	2009

3 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Osseous Paget's Disease

Article	Year
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:3 Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Osteitis Deformans; Pain; Quality of Life; Time Factors; Treatment Outcome; Vitamin D	2011
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007, Volume: 22, Issue:10 Topics: Aged; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Osteitis Deformans; Pain; Pamidronate; Quality of Life; Time Factors; Zoledronic Acid	2007
Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate. Bone, 1998, Volume: 23, Issue:6 Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Resistance; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Peptides; Recurrence; Treatment Outcome	1998

4 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Osseous Paget's Disease

Article	Year
Treatment of Paget's disease of the bone: long-term effect of neridronate in a real-life setting. Minerva endocrinology, 2021, Volume: 46, Issue:4 Topics: Aged; Bone and Bones; Diphosphonates; Female; Humans; Osteitis Deformans; Prospective Studies	2021
Reumatismo, 2016, Dec-16, Volume: 68, Issue:3 Topics: Administration, Intravenous; Adult; Bone Density Conservation Agents; Delayed Diagnosis; Diphosphonates; Female; Humans; Mandible; Osteitis Deformans; Treatment Outcome	2016
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone. Clinical rheumatology, 2017, Volume: 36, Issue:4 Topics: Adaptor Proteins, Signal Transducing; Aged; Bone Morphogenetic Proteins; Bone Remodeling; Case-Control Studies; Collagen Type I; Diphosphonates; Female; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Italy; Male; Middle Aged; Osteitis Deformans; Peptides; Wnt Signaling Pathway	2017
Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate. The American journal of medicine, 1987, Volume: 83, Issue:2 Topics: Aged; Aged, 80 and over; Biopsy; Bone and Bones; Diphosphonates; Drug Evaluation; Drug Resistance; Etidronic Acid; Female; Humans; Ilium; Male; Middle Aged; Osteitis Deformans; Radiography; Radionuclide Imaging; Time Factors	1987